The future of atrial fibrillation therapy

Autor: van Denise Marion, N. M. S. de Groot, Bianca J. J. M. Brundel, Eva A.H. Lanters, Herman Steen

Publikováno v: Netherlands Heart Journal, 23(6), 327-333. Bohn Stafleu van Loghum
Lanters, E A H, van Marion, D M S, Steen, H, de Groot, N M S & Brundel, B J J M 2015, ' The future of atrial fibrillation therapy: intervention on heat shock proteins influencing electropathology is the next in line ', Netherlands Heart Journal, vol. 23, no. 6, pp. 327-333 . https://doi.org/10.1007/s12471-015-0699-0
Netherlands Heart Journal
Netherlands Heart Journal, 23(6), 327-333. Bohn, Stafleu, Van Loghum

Atrial fibrillation (AF) is the most common agerelated cardiac arrhythmia accounting for one-third of hospitalisations. Treatment of AF is difficult, which is rooted in the progressive nature of electrical and structural remodelling, called electropa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab79b5e8ec735ba1d1dcfac4a30ee62b
https://doi.org/10.1007/s12471-015-0699-0